Answer
Regadenoson activates the A2A adenosine receptor, producing coronary vasodilation and increasing coronary blood flow.
Sources for this answer
- Rapiscan 400 microgram solution for injectionGE Healthcare Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked